SignatureFD’s Kyverna Therapeutics KYTX Stock Holding History
Bought
Maintained
Sold
Other funds holding KYTX
ACM
SignatureFD's KYTX Position: Q3 2026 in Review
SignatureFD sold out of Kyverna Therapeutics (KYTX) in Q3 2026, closing a stake of 466 shares — an estimated $4.15K sold.
SignatureFD first reported a position in KYTX in Q3 2024 and held it in 2 quarters. The position peaked at $4.15K in Q2 2026. 128 funds tracked by Wall St. Rank hold KYTX as of Q3 2026.
- SignatureFD reported no remaining Kyverna Therapeutics position as of Q3 2026 after selling out during the quarter.
- SignatureFD sold 466 Kyverna Therapeutics shares in Q3 2026, an estimated $4.15K.
- SignatureFD first reported a position in Kyverna Therapeutics in Q3 2024 and held it in 2 quarters.
- SignatureFD's Kyverna Therapeutics position peaked at $4.15K in Q2 2026.
- 128 funds tracked by Wall St. Rank held Kyverna Therapeutics as of Q3 2026.
Based on SignatureFD's 13F filing for Q3 2026, filed 23 Oct 2026.